| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |